Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SSc-Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Testing effectiveness (Phase 2)Looking for participantsNCT07641634
What this trial is testing

PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

Who this might be right for
Healthy VolunteersSystemic Sclerosis (SSc)Scleroderma, Systemic+1 more
Prolium Bioscience, Inc 44
Not applicableNot Yet RecruitingNCT06769399
What this trial is testing

Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Sexual DysfunctionsPelvic Floor Disorder
Istanbul University - Cerrahpasa 140
Very early researchNot Yet RecruitingNCT06982534
What this trial is testing

Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.

Who this might be right for
Systemic Sclerosis (SSc)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Not applicableLooking for participantsNCT06894654
What this trial is testing

DERMATOMICS: Identifying Regulators of Skin Homeostasis

Who this might be right for
Systemic Sclerosis (SSc)
Relation Therapeutics 500
Not applicableStudy completedNCT02837549
What this trial is testing

Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma

Who this might be right for
SclerodermaSsc
University of Michigan 21
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Early research (Phase 1)Not Yet RecruitingNCT07523282
What this trial is testing

Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Sclerosis (SSc)
Shenzhen MagicRNA Biotechnology Co., Ltd 12
Not applicableStudy completedNCT07402863
What this trial is testing

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

Who this might be right for
Systemic Sclerosis
University of Michigan 43
Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Testing effectiveness (Phase 2)Ended earlyNCT02745145
What this trial is testing

Abituzumab in SSc-ILD

Who this might be right for
Systemic Sclerosis-associated Interstitial Lung Disease
EMD Serono Research & Development Institute, Inc. 24
Very early researchLooking for participantsNCT07526350
What this trial is testing

MTS109 in Patients With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis (SSc)+2 more
Shanghai Changzheng Hospital 15
Testing effectiveness (Phase 2)UnknownNCT00962923
What this trial is testing

Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)

Who this might be right for
Systemic SclerosisMesenchymal Stem Cells
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Early research (Phase 1)WithdrawnNCT06913608
What this trial is testing

Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
Calibr, a division of Scripps Research
Very early researchNot Yet RecruitingNCT07072884
What this trial is testing

GC012F in Patients With Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
Qiong Fu 15
Large-scale testing (Phase 3)Looking for participantsNCT07245238
What this trial is testing

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Who this might be right for
MediciineSystemic Sclerosis (SSc)Intervention Study
Khon Kaen University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07800871
What this trial is testing

FT839 in Autoimmune Diseases

Who this might be right for
ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more
Fate Therapeutics 446
Next Page